New Jersey Startup Launches With Clinical Assets From Big Name Biotechs Post author:Sam Post published:August 21, 2017 Post category:BioPharma August 22, 2017By Mark Terry<… Source: BioSpace You Might Also Like Mallinckrodt Pays $117M for This Bay Area Biotech and Its Failed Liver Drug November 1, 2017 GlaxoSmithKline Poaches Another Top Exec—This Time From Pfizer July 12, 2017 Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+ August 16, 2017
